RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
President and CEO Emil D Kakkis sold $1.1M of Ultragenyx Pharmaceutical Inc.
Sold$1,117,000
$55.85Price
20,000Shares
−1%Stake
What RARE did after the filing
- The stock from Thu, Sep 5 close, $56.45
- +0.6%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Oct 17 close.
Traded Tue, Sep 3. Filed Thu, Sep 5, 11:53 AM ET, during the session. Returns use the Sep 5 close and the Oct 17 close. Not investment advice.